• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 0.29% Nasdaq Down 0.03%

    Aratana Therapeutics, Inc. (PETX)

    -NasdaqGM
    13.41 Down 0.10(0.74%) May 22, 4:00PM EDT
    Add to Portfolio
    Prev Close:13.51
    Open:13.53
    Bid:12.02 x 100
    Ask:18.99 x 100
    1y Target Est:27.57
    Beta:5.808
    Earnings Date:Aug 10 - Aug 14 (Est.)
    Day's Range:13.25 - 13.74
    52wk Range:9.20 - 20.63
    Volume:83,707
    Avg Vol (3m):245,723
    Market Cap:468.14M
    P/E (ttm):N/A
    EPS (ttm):-1.22
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for PETX

    Comparison

    Symbol% ChgMkt Cap
    PETXDown 0.74%468.14M
    ZTSDown 0.36%23.81B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):618.40
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :-1.46
    Quarterly EPS Est (Jun-15) :-0.37
    Mean Recommendation*:1.5
    PEG Ratio (5 yr expected):-0.62

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Aratana Therapeutics, Inc., a development-stage biopharmaceutical company, focuses on the licensing, development, and commercialization of biopharmaceutical products for the companion animals worldwide. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback